Insulet (PODD) Q2 Revenue Beats
Tweet
Share
E-mail
Get Alerts PODD Hot Sheet
Price: $140.60 -0.67%
Revenue Growth %: +18.1%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +18.1%
Financial Fact:
Research and development: 13.73M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q2 EPS of ($0.50), which may not compare to the analyst estimate of $0.22. Revenue for the quarter came in at $299.4 million versus the consensus estimate of $291.45 million.
GUIDANCE:
For the year ending December 31, 2022, the Company is raising its revenue growth guidance range to 14% to 17% (previously 12% to 16%). Revenue growth ranges by product line are:
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Amneal gets FDA approval for lanreotide injection, launches immediately
- Anthropic delays planned IPO from October to November - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
